Neuropeptide S: a novel modulator of stress and arousal
- PMID: 17613937
- DOI: 10.1080/10253890701248673
Neuropeptide S: a novel modulator of stress and arousal
Abstract
Neuropeptide S (NPS) is a recently identified bioactive peptide that modulates stress and arousal. NPS is expressed in a few discrete nuclei in the brainstem, such as the pericoerulear (locus coeruleus (LC)) area and the parabrachial nucleus. NPS activates its cognate G protein-coupled receptor at low nanomolar agonist concentrations and induces elevation of intracellular Ca2+ and cAMP, therefore acting as an excitatory transmitter. The NPS receptor is widely expressed in the brain, including regions known to regulate stress responses such as hypothalamus, thalamus, amygdala and limbic cortex. We have recently reported that the NPS system can modulate stress responses and induce wakefulness based on a battery of behavioral tests. Activation of NPS receptors induces arousal and reduces all sleep stages. At the same time, NPS produces anxiolytic-like effects in rodents. These studies indicate that the NPS system has a unique pharmacological profile to promote both anxiolytic and arousal effects. NPS might interact with other hypothalamic neuropeptide systems that are known to be involved in stress and appetite control and thus might be a valuable target for development of a new class of drugs to treat anxiety disorders.
Similar articles
-
Neuropeptide S as a novel arousal promoting peptide transmitter.FEBS J. 2005 Nov;272(22):5689-93. doi: 10.1111/j.1742-4658.2005.04982.x. FEBS J. 2005. PMID: 16279934 Review.
-
Neuropeptide S: a new player in the modulation of arousal and anxiety.Mol Interv. 2005 Feb;5(1):42-6. doi: 10.1124/mi5.1.8. Mol Interv. 2005. PMID: 15731503 Review.
-
Neuropeptide S and its receptor: a newly deorphanized G protein-coupled receptor system.Neuroscientist. 2005 Dec;11(6):532-8. doi: 10.1177/1073858405276405. Neuroscientist. 2005. PMID: 16282594 Review.
-
Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.Neuron. 2004 Aug 19;43(4):487-97. doi: 10.1016/j.neuron.2004.08.005. Neuron. 2004. PMID: 15312648
-
Neuropeptide S: anatomy, pharmacology, genetics and physiological functions.Results Probl Cell Differ. 2008;46:145-58. doi: 10.1007/400_2007_051. Results Probl Cell Differ. 2008. PMID: 18204825 Review.
Cited by
-
Dynorphin-Dependent Reduction of Excitability and Attenuation of Inhibitory Afferents of NPS Neurons in the Pericoerulear Region of Mice.Front Cell Neurosci. 2016 Mar 11;10:61. doi: 10.3389/fncel.2016.00061. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27013974 Free PMC article.
-
Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model.Front Mol Neurosci. 2018 Jun 25;11:201. doi: 10.3389/fnmol.2018.00201. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30013462 Free PMC article.
-
Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex.J Neurochem. 2010 Oct;115(2):475-82. doi: 10.1111/j.1471-4159.2010.06947.x. Epub 2010 Aug 30. J Neurochem. 2010. PMID: 20722970 Free PMC article.
-
Role of the Neuropeptide S System in Emotionality, Stress Responsiveness and Addiction-Like Behaviours in Rodents: Relevance to Stress-Related Disorders.Pharmaceuticals (Basel). 2021 Aug 8;14(8):780. doi: 10.3390/ph14080780. Pharmaceuticals (Basel). 2021. PMID: 34451877 Free PMC article. Review.
-
Neuropeptide S (NPS) variants modify the signaling and risk effects of NPS Receptor 1 (NPSR1) variants in asthma.PLoS One. 2017 May 2;12(5):e0176568. doi: 10.1371/journal.pone.0176568. eCollection 2017. PLoS One. 2017. PMID: 28463995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous